We are live on
!
Find out more
ETM
Euclidean Technologies Management Portfolio holdings
AUM
$109M
1-Year Est. Return
7.18%
This Fund
S&P 500
This Quarter
Est. Return
-16.35%
1 Year Est. Return
+7.18%
3 Year Est. Return
+123.73%
5 Year Est. Return
+76.06%
10 Year Est. Return
–
AUM
$96.2M
AUM Growth
-$17.1M
(-15%)
Cap. Flow
+$2.62M
Cap. Flow
% of AUM
2.73%
Top 10 Holdings %
Top 10 Hldgs %
22.74%
Holding
70
New
8
Increased
18
Reduced
7
Closed
5
Top Buys
| 1 |
EGOV
NIC Inc
EGOV
|
+$1.88M |
| 2 |
Ethan Allen Interiors
ETD
|
+$1.79M |
| 3 |
Steel Dynamics
STLD
|
+$1.61M |
| 4 |
Cigna
CI
|
+$1.28M |
| 5 |
TD Synnex
SNX
|
+$1.16M |
Top Sells
| 1 |
Elevance Health
ELV
|
+$2.71M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$2.4M |
| 3 |
Humana
HUM
|
+$2.32M |
| 4 |
Pitney Bowes
PBI
|
+$1.42M |
| 5 |
CVS Health
CVS
|
+$1.13M |
Sector Composition
| 1 | Consumer Discretionary | 34.91% |
| 2 | Industrials | 22.99% |
| 3 | Technology | 10.76% |
| 4 | Communication Services | 10.48% |
| 5 | Healthcare | 6.47% |
Similar funds
CWM
ACM
RA
AMC
BCM
HLCM
TWP
PCM
Euclidean Technologies Management's Q4 2018 Portfolio in Review
As of Q4 2018, Euclidean Technologies Management held 70 positions worth $96.2M, down 15% from $113M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Euclidean Technologies Management's Q4 2018 filing shows 8 new, 18 increased, 7 reduced and 5 closed positions. Its largest new stake was NIC Inc: 140,920 shares worth $1.76M. The largest sale was Elevance Health, an estimated $2.71M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 35% of assets, up from 33% a quarter earlier, followed by Industrials and Technology.
- Euclidean Technologies Management's largest Q4 2018 buy was NIC Inc: 140,920 shares worth $1.76M.
- Euclidean Technologies Management added most to American Public Education in Q4 2018, an estimated $1.14M increase.
- Euclidean Technologies Management's biggest Q4 2018 reduction was CVS Health, cutting an estimated $1.13M.
- Euclidean Technologies Management fully exited Elevance Health in Q4 2018, selling an estimated $2.71M.
- Euclidean Technologies Management's ten largest holdings make up 23% of its $96.2M portfolio in Q4 2018.
- Euclidean Technologies Management opened 8 new positions and closed 5 in Q4 2018.
- Euclidean Technologies Management's portfolio value fell 15% quarter-over-quarter to $96.2M.
Based on Euclidean Technologies Management's 13F filing for Q4 2018, filed 14 Feb 2019.